Conference Coverage

VIDEO: Investigating the role of plasmalogens in Alzheimer’s disease


 

AT AAIC 2015

References

WASHINGTON – Could a ubiquitous lipid – manufactured in the liver – be one of the root causes of Alzheimer’s disease? Plasmalogens are important in maintaining cell membrane permeability and effective neurotransmission. They also appear to influence the production of toxic forms of amyloid-beta by affecting the activity of alpha-secretase. What are they, and how strong could their influence in Alzheimer’s be? Dayan Goodenowe, Ph.D., explains at the Alzheimer’s Association International Conference 2015.

Dr. Goodenowe is the founder and CEO of Phenomenome Discoveries, which holds patents on measuring plasmalogen levels and is developing a plasmalogen therapeutic.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Recommended Reading

VIDEO: Consider adult ADHD in dementia differential diagnosis
MDedge Psychiatry
Oil- and nut-supplemented Mediterranean diet improves elderly cognition
MDedge Psychiatry
Prevalence of amyloid pathology differs across dementia type and age
MDedge Psychiatry
PSYCHIATRY UPDATE 2015
MDedge Psychiatry
Cortical volume linked to IQ changes in schizophrenia
MDedge Psychiatry
Provide your patients with a DEFENSE against age-related cognitive decline
MDedge Psychiatry
Consider telehealth technology to perform reliable and valid cognitive screening
MDedge Psychiatry
Mixed pathologies are very common in black Alzheimer’s patients
MDedge Psychiatry
AAIC: Sedentary early adulthood may mean worse cognitive functioning later
MDedge Psychiatry
VIDEO: Dementia risk doubled in type 1 diabetes patients
MDedge Psychiatry